“In the history of medicine, this may be the most exciting and productive period,” writes Ian Read, CEO of Pfizer, in Forbes. “At the same time, we are about to make major changes in our government that may give us the opportunity we need to take advantage of this renaissance.”

“But not all Americans can gain access to these wonders. It is a completely unacceptable state of affairs when sick people can’t afford their medicines or take advantage of scientific progress.”